SciELO - Scientific Electronic Library Online

 
vol.111 número2Respuesta neonatal frente al olor del líquido amnióticoComparación del riesgo de contaminación de la leche materna extraída en una unidad de cuidados intensivos neonatales y en el hogar índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Archivos argentinos de pediatría

versión impresa ISSN 0325-0075

Resumen

LIERN, Miguel; BOHORQUEZ, Mónica  y  VALLEJO, Graciela. Treatment of idiopathic hypercalciuria and its impact on associated diseases. Arch. argent. pediatr. [online]. 2013, vol.111, n.2. ISSN 0325-0075.  http://dx.doi.org/10.5546/aap.2013.110.

Idiopathic hypercalciuria may be associated with urinary tract infection, hematuria, nephrolithiasis and osteopenia. In order to describe the occurrence of these concurrent conditions related to the variation in urinary calcium and hypercalciuria response to sequential therapy, with a normal protein and low sodium diet, potassium citrate and hydrochlorothiazide; 46 patients older than 4 years, with no urinary tract diseases, sphincter control and normal blood creatinine values were followed-up during 43 months. Hypercalciuria was seen to be associated with kidney stones (EAR 47%; RR 3.3), hematuria (EAR 71%; RR 2.5), urinary tract infections (EAR 57%; RR 3), and osteopenia (EAR 33%; RR 3). A normal value of urinary calcium was achieved with sequential therapy in 43 patients, but during follow-up 32 patients discontinued treatment and hypercalciuria recurred in 44% of them, in association with hematuria and urinary tract infection. Conclusions. Sequential therapy reduced hypercalciuria and the incidence of associated diseases.

Palabras clave : Hypercalciuria; Hematuria; Urinary tract infection; Osteopenia; Nephrolithiasis.

        · resumen en Español     · texto en Inglés     · Español ( pdf ) | Inglés ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons